FUJIFILM Diosynth to manufacture biologics for Regeneron at new facility in Holly Springs, North Carolina.

Overcoming the limitations of the triple plasmid transient transfection method for AAV manufacturing.

We speak with Colorcon CEO Simon Tasker about the importance of the patient experience when it comes to medicines.

Trump signs executive order on lowering drug prices and amends Medicare price negotiation for small molecule drugs.

Simon Tasker joined Colorcon as a bench chemist – and never left. Today, he’s the company’s CEO. Here’s how his career unfolded.

The political situation in the US and its impact on science and medicine is changing rapidly. Here’s a quick look at the latest developments.

Discussing the development of trends, treatments, and talent in gene therapy with NewBiologix CEO Igor Fisch.

Open-access research paper outlines quality and regulatory considerations for cell therapy manufacturing programs.

ADCs have shown their promise, but the next step is realizing their potential.

Lore Gruenbaum discusses The Leukemia & Lymphoma Society, advances in blood cancers, and the role of nonprofits.